The last full day meeting was held by the Leeds Team at the Weetwood Hotel on Tuesday 25th November.

We would like to thank all of those who could attend, and those who presented a talk at the meeting.

The name of the metting was Diagnosis, Imaging, and Treatment of Retina Diseases, and the agenda for the day was as followed:

9.00 am               Registration with refreshments

9.15 am                Introduction and Welcome

9.20 am                Diabetic Retinopathy Screening – What’s new and the impact of systemic therapies

                              Presented by Samantha Mann

09.40 am             Management of Proliferative Diabetic Retinopathy – Optimal treatment strategies in 2025

                              Presented by Moin Mohamed

10.00 am             OCT Biomarkers as a guide to individualised therapy in Diabetic Macular Oedema

                              Presented by Deepali Varma

10.20 am             Questions

10.30 am             Tea/Coffee Break and Exhibition Viewing

11.00 am             Ultra-widefield OCT-angiography

                              Presented by Tariq Aslam

11.30 am             Leeds data on Faricimab for RVO

                              Presented by Ewa Migdal-Butlin

11.45 am             Ultrawide-field OCT-A in RVO

                              Presented by Aditi Mohla

12.00 pm             Ocular trauma from the VR surgeon’s perspective

                              Presented by Roxane Hillier

12.30 pm             Questions

12.45 pm            Lunch and Exhibition Viewing

13.45 pm             Trainee Case Presentations

14.30 pm             Gene therapy for neovascular AMD

                              Presented by Dominik Fisher

14:50 pm             Questions

15.00 pm             Population Prevalence and Staging of PVD using OCT

                              Presented by Tien-En Tan     

15.10 pm             Tea / Coffee Break and Exhibition Viewing

15.40 pm             Real-world evidence for and safety profile of Faricimab 6 mg

                              Presented by Ian Pearce

16:10 pm             Real-world evidence for and safety profile of Aflibercept 8 mg

                              Presented by Serena Salvatore

16.40 pm             Questions

16.50 pm             Service planning for Biosimilar usage – Local experience and
                               successes

                              All local units invited to contribute

Evaluation - Please find attached Evaluation Form for the Winter 2025 meeting here. 

Attendance Certificate - will be email once the Evaluation Form is complete. Please ensure you have inputted your email address on the Evaluation Form.